Carey Ng

Satiogen Pharmaceuticals, Inc. engages in the development of therapeutic treatments for diabetes and obesity. It offers a metabolic mechanism for treating diabetes and obesity without intervention by systemically absorbed pharmaceuticals or invasive surgical methods. The firm’s product strategies include non-absorbed ASBT inhibitor, non-surgical biliary shunt, rectal satiogen, non-absorbed TGR5 ligand and labile bile acid sequestrant. The company was founded by Andrew Young and Bronislava Gedulin in 2007 and is headquartered in Del Mar, CA.

Mesa Verde Ventures LLC (Mesa Verde Ventures) is a venture capital firm founded in 2006. The firm is headquartered in San Diego, California.

Paradigm Diagnostics, Inc. develops, manufactures and distributes high throughput microbiological screening tests. It has developed and is currently selling diagnostic tests to the food processing industry that allow them to screen environmental samples for pathogens in- house. The company was founded by Alan D. Olstein in 2001 and is headquartered in St. Paul, MN.

Elysium Therapeutics, Inc. develops pain relievers. The company was founded by Alex Gregory Sturmer and Thomas E. Jenkins in 2013 and is headquartered in Akron, OH.

MatriSys Bioscience, Inc. engages in the development of biologic therapeutics. It offers therapies for dermatology and skin care conditions including atopic dermatitis, rosacea, psoriasis, acne, and skin infections. The company was founded by Mark S. Wilson and Richard L. Gallo in 2015 and is headquartered in La Jolla, CA.

Mesa Verde Venture Partners LP seeks investment opportunities in companies located in the US. The fund targets companies operating in the fields of drug discovery/tools, medical devices & diagnostics and healthcare information technology. It provides financing for early stage capital requirements with an investment size of $0.5 - $1.5 million per company.

Biscayne Neurotherapeutics, Inc. engages in the development of novel treatments for epilepsy, pain and other central nervous system (CNS) disorders. The company was founded by Samuel J. Reich on November 15, 2011 and is headquartered in Miami, FL.